Yesterday was National Cancer Survivors’ Day. At ASCO in Chicago last week, three cancer survivors shared parts of their ...

This year, the transformation of China’s biotech and pharma industry into a dominant global player has only accelerated.

Incyte has agreed to buy Star Therapeutics subsidiary Vega Therapeutics for $1.25 billion upfront, adding a late-stage drug ...

Boehringer Ingelheim revealed more data behind previously reported top-line results for its dual-acting obesity drug ...

Alongside the weight-loss result, however, were significant improvements in knee osteoarthritis pain, with an improvement of ...

Yet, while excitement around disruptive technologies remains high, bringing genuinely transformative healthcare innovations ...

Johnson & Johnson has continued to build its presence in KRAS-targeting drugs for cancer with a $1 billion agreement to buy Firefly Bio and its degrader-antibody conjugate (DAC) platform. The all-cash ...

Roche is preparing to file one BTK-targeting drug for approval, and has just added another with potential across oncology, immunology, and neurology via a deal with Nurix Therapeutics. The licensing ...

An AI-designed vaccine against all variants of the coronavirus SARS-CoV-2 – designed using an AI-powered platform developed ...

A PCR diagnostic developed by Roche for the Bundibugyo form of Ebola is being offered to health systems at the front lines of ...

Analysts suggested the deaths could overshadow the PFS results, and the safety trade-off may make it harder for ADC ...

Multiple sclerosis (MS) is undergoing a meaningful evolution in how it is understood, diagnosed, and managed. Advances in ...